Home Careers Site Map Contact Us
 
 
   
 
Investor & Shareholders < Financial < Home
Financial   Notices and Results
Corporate Policies
Corporate Governance
Shareholding Patterns
 
The investors should mark all their Complaints/Requests to investor_complaints@sharonbio.com
 
NCLT-Regulation 13-List of creditors
Public announcment
Letter of USFDA Approval for API Plant NSE
Letter of USFDA Approval for API Plant BSE
1st Quarter Board Meeting
2nd Quarter Board Meeting
3rd Quarter Board Meeting
4th Quarter Notice for Financial Results 31 March 2017
27th Annual General Meeting
Letter of Resignation Mr. Harish & Dr. Nivedita
Letter for extension of AGM
Extension Letter for CIRP Period
Notice Transfer of Equity Shares of the Company to Investor(IEPF)
AGM Results- REGULATION 44(3)
Filling Under Regulation 13
Unpaid Dividend
Notice For Adoption of Financial Results For the Quarter Ended June, September & December 2017
Appointment of Nodal Officer for IEPF process
Board Meeting for Q4 Results_30.05.2018
Appointment of Mr. Kaushik Banerjee as Chief Executive Officer
Resignation of Mrs. Savita Gowda & Mr. Lalit Misra
Intimation Meeting for Quarter1 Results 14-Aug-2018
Intimation of Change in Corporate Office Address
Intimation letter for the quarter ended 30 September, 2018
Amendment to Regulation 40
 
     
 
 
website designers mumbai